Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 174 member A (FAM174A) is a poorly characterized membrane protein carrying a domain of unknown function (DUF1180). It is expressed in various tissues and has been implicated in diverse biological processes, including cholesterol and lipid metabolism, metabolic homeostasis, and developmental pigmentation in animal models. Recent studies have connected it to oncogenic roles, notably through the formation of fusion genes such as FAM174A-WWC1 in early-onset colorectal cancer, where the fusion protein disrupts cell adhesion and perturbs Hippo pathway signaling, increasing tumorigenic potential. Genome-wide analyses also suggest its involvement in metabolic syndrome and rare variants in neurodegenerative disease, but direct therapeutic targeting, established disease biomarkers, or drug interactions for FAM174A remain undocumented. Its precise mechanism(s) and molecular partners remain largely unknown and warrant further research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 174 member A (FAM174A).